Wealth Enhancement Advisory Services
OKYO

Wealth Enhancement Advisory Services’s OKYO Pharma OKYO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$21.2K – 3792
2025
Q4 		$21.2K Hold
10,000
– – ﹤0.01% 3585
2025
Q3 		$20.3K Hold
10,000
– – ﹤0.01% 3509
2025
Q2 		$27.8K Buy
+10,000
New +$16.9K ﹤0.01% 3272

Other funds holding OKYO

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM

Wealth Enhancement Advisory Services's OKYO Position: Q1 2026 in Review

Wealth Enhancement Advisory Services sold out of OKYO Pharma (OKYO) in Q1 2026, closing a stake of 10,000 shares — an estimated $21.2K sold.

Wealth Enhancement Advisory Services first reported a position in OKYO in Q2 2025 and held it in 3 quarters. The position peaked at $27.8K in Q2 2025. 12 funds tracked by Wall St. Rank hold OKYO as of Q1 2026.

  • Wealth Enhancement Advisory Services reported no remaining OKYO Pharma position as of Q1 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 10,000 OKYO Pharma shares in Q1 2026, an estimated $21.2K.
  • Wealth Enhancement Advisory Services first reported a position in OKYO Pharma in Q2 2025 and held it in 3 quarters.
  • Wealth Enhancement Advisory Services's OKYO Pharma position peaked at $27.8K in Q2 2025.
  • 12 funds tracked by Wall St. Rank held OKYO Pharma as of Q1 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q1 2026, filed 8 Apr 2026.